Eines der wichtigsten Wissenschaftsjournale der Welt, das British Medical Journal, kritisiert die Geheimniskrämerei rund um die Impf-Studien.

Covid-19 vaccines and treatments: we must have raw data, now! Data should be fully and immediately available for public scrutiny

Peter Doshi, senior editor,  

Fiona Godlee, former editor in chief,  

Kamran Abbasi, editor in chief

„In the pages of The BMJ a decade ago, in the middle of a different pandemic, it came to light that governments around the world had spent billions stockpiling antivirals for influenza that had not been shown to reduce the risk of complications, hospital admissions, or death. The majority of trials that underpinned regulatory approval and government stockpiling of oseltamivir (Tamiflu) were sponsored by the manufacturer; most were unpublished, those that were published were ghostwritten by writers paid by the manufacturer, the people listed as principal authors lacked access to the raw data, and academics who requested access to the data for independent analysis were denied.“

Unacceptable delay

Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data. And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date, which is listed on ClinicalTrials.gov as 15 May 2023.“

„Big pharma is the least trusted industry. At least three of the many companies making covid-19 vaccines have past criminal and civil settlements costing them billions of dollars. One pleaded guilty to fraud. Other companies have no pre-covid track record. Now the covid pandemic has minted many new pharma billionaires, and vaccine manufacturers have reported tens of billions in revenue.“


0 Kommentare

Schreibe einen Kommentar

Avatar-Platzhalter

Deine E-Mail-Adresse wird nicht veröffentlicht.